NUPR1 is a novel potential biomarker and confers resistance to sorafenib in clear cell renal cell carcinoma by increasing stemness and targeting the PTEN/AKT/mTOR pathway-Reference-Cited by-同舟云学术

NUPR1 is a novel potential biomarker and confers resistance to sorafenib in clear cell renal cell carcinoma by increasing stemness and targeting the PTEN/AKT/mTOR pathway

Published:2021-05-24 Issue:10 Volume:13 Page:14015-14038
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

He Wei¹²,Cheng Fajuan³⁴,Zheng Bin²,Wang Jianwei⁵,Zhao Guiting¹,Yao Zhongshun¹,Zhang Tong¹²

Affiliation:

1. Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China

2. Department of Urology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China

3. Department of Nephrology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong, China

4. Department of Nephrology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China

5. Department of Urology, Shandong Provincial ENT Hospital Affiliated to Shandong University, Jinan, Shandong, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Ageing

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decoding PTEN regulation in clear cell renal cell carcinoma: Pathway for biomarker discovery and therapeutic insights;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

2. Elevated histone deacetylase 10 expression promotes the progression of clear cell renal cell carcinoma by Notch-1-PTEN signaling axis;Discover Oncology;2024-05-11

3. Natural products for combating multidrug resistance in cancer;Pharmacological Research;2024-04

4. ATF4/NUPR1 axis promotes cancer cell survival and mediates immunosuppression in clear cell renal cell carcinoma;2024-02-20

5. Retinoic Acid Boosts HIV-1 Replication in MacrophagesviaCCR5/SAMHD1-Dependent and mTOR-Modulated Mechanisms;2023-10-06